Heart Valve Deal Was Blocked Over Innovation Concerns

By Matthew Perlman · January 23, 2026, 8:14 PM EST

The D.C. federal court ruling earlier this month that upended a deal for Edwards Lifesciences Corp. to purchase JenaValve Technology Inc. was based on concerns that the deal would reduce innovation...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

FEDERAL TRADE COMMISSION v. EDWARDS LIFESCIENCES CORPORATION et al

Case Number

Court

District Of Columbia

Nature of Suit

Anti-Trust

Date Filed

August 06, 2025

Recent Articles By Matthew

January 21, 2026
BCBS Says Bankrupt Hospital Can't Leave $3B Antitrust Deal
January 12, 2026
CareFirst Opposes J&J's Bid To Revisit Stelara Antitrust Case
January 09, 2026
Veterinary Group Says DOJ Accreditation Points Irrelevant
January 09, 2026
Judge Blocks Edwards' $945M Heart Valve Deal
December 15, 2025
DOJ Raises Accreditation Concerns In Vet School Case
December 04, 2025
Prolonged FTC Review Kills $615M Healthcare Staffing Deal
November 26, 2025
GTCR Drops FTC Constitutional Challenge Over Merger Case
November 24, 2025
FTC Abandons In-House GTCR Merger Case After Court Loss
November 21, 2025
PBMs Say Gov't Benefits From Drug Rebates FTC Condemns
November 20, 2025
FTC Withdraws In-House GTCR Merger Case